News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
227 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26499)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
AiCuris to Pocket $122M as Merck Wins FDA Approval for New CMV Infection Drug
CMV is a common and potentially serious viral infection in allogeneic HSCT recipients.
November 9, 2017
·
2 min read
·
Mark Terry
Business
Bay Area’s Principia Biopharma Scores $765M MS Licensing Deal With Drug Giant Sanofi
Sanofi will write a check for $40 million upfront.
November 9, 2017
·
2 min read
·
Alex Keown
Business
Leti Joins DARPA-Funded Consortium of Seeing and Hearing Foundation to Develop Implantable Device for Restoring Vision
Leti announced today that a team of its researchers is participating in a U.S.-funded project to develop a safe, implantable neural interface system to restore vision by stimulating the visual cortex.
November 9, 2017
·
4 min read
FDA
How Sweet It Is: Dynavax Finally Wins FDA OK for Hep B Vaccine Heplisav
The FDA approved Dynavax’s Heplisav-B, it’s first new hepatitis B vaccine in the U.S. in more than 25 years.
November 9, 2017
·
2 min read
·
Mark Terry
Business
Xtant Medical Postpones Release of Third Quarter 2017 Financial Results
The Company now plans to release its third quarter 2017 financial results in conjunction with the filing of its 10-Q which is currently expected to occur by November 20, 2017.
November 9, 2017
·
1 min read
Biotech Beach
AcuFocus Release: KAMRA Corneal Inlay Delivers Uncompromised Vision for Presbyopic Patients
With the KAMRA inlay, you can restore your reading vision while maintaining great distance vision by extending your overall depth of focus.
November 9, 2017
·
4 min read
Oncimmune: Launch of ‘Finger Stick’ Sample Collection for EarlyCDT-Lung
Simplified blood sample collection procedure introduces ease of use and quicker results.
November 9, 2017
·
3 min read
Business
Median Technologies Appoints Dr. Peter Bannister as Chief Technology Officer
As Chief Technology Officer, Dr. Bannister is responsible for leading the development and scientific research teams at Median and ensuring that Median’s products directly address the unmet healthcare needs identified by the company’s clinical end users.
November 9, 2017
·
4 min read
FDA
FDA Approves Seattle Genetics’ Adcetris to Treat Disfiguring Blood Cancer
The approval is based on data from the phase 3 ALCANZA trial and two phase 2 investigator-sponsored trials.
November 9, 2017
·
16 min read
Business
Dr. Charles J. Fisher, Jr. Joins Aethlon Medical’s Board of Directors
Dr. Fisher qualifies as an independent director under the Nasdaq Rules, and his appointment fills an open Board seat.
November 9, 2017
·
5 min read
Previous
2 of 23
Next